These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 7511068)

  • 21. Use of fructose 1,6-diphosphate aldolase to detect tumour necrosis after transcatheter arterial embolization of hepatocellular carcinoma.
    Khan KN; Nakata K; Kusumoto Y; Nakao K; Kato Y; Nagataki S
    J Gastroenterol Hepatol; 1998 Feb; 13(2):192-6. PubMed ID: 10221823
    [TBL] [Abstract][Full Text] [Related]  

  • 22. High-dose iodized oil transcatheter arterial chemoembolization for patients with large hepatocellular carcinoma.
    Chen MS; Li JQ; Zhang YQ; Lu LX; Zhang WZ; Yuan YF; Guo YP; Lin XJ; Li GH
    World J Gastroenterol; 2002 Feb; 8(1):74-8. PubMed ID: 11833075
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Anticancer and side effect of arterial subsegmental chemoembolization using cisplatinum/pirarubicin lipiodol suspension (CTLS) for hepatocellular carcinoma].
    Inoue H; Miyazono N; Kanetsuki I; Hori A; Tanaka D; Fukukura Y; Matsumoto Y; Nishida H; Ueno K; Nakajo M
    Gan To Kagaku Ryoho; 1993 Oct; 20(13):1973-6. PubMed ID: 7692822
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Volumetric and morphological CT parameters for assessing prognosis and treatment control in hepatocellular carcinoma undergoing arterial chemoembolization].
    Vogl TJ; Trapp M; Pegios W; Mack M; Bechstein WO; Keck W; Scholz A; Schröder H; Neuhaus P; Felix R
    Rofo; 1997 Sep; 167(3):219-26. PubMed ID: 9376548
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [The clinical course of nodular type hepatocellular carcinomas after transcatheter arterial embolization (TAE) therapy].
    Suyama Y; Kitagawa Y; Horishi M; Shizumi Y; Yashige H; Fujii H; Miyoshi M
    Gan No Rinsho; 1989 Aug; 35(9):983-9. PubMed ID: 2475651
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [External radiation and combined transcatheter arterial chemoembolization for unresectable primary liver cancer].
    Liu MZ; Wang XS; Cai L; Gu MF; Liu H; Li Q; Cui NJ; Zhang YQ; Li GH; Li JQ
    Ai Zheng; 2005 Jan; 24(1):82-6. PubMed ID: 15642207
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Transcatheter hepatic subsegmental arterial chemoembolization therapy using iodized oil for small hepatocellular carcinomas. Correlation between lipiodol accumulation pattern and local recurrence.
    Murakami R; Yoshimatsu S; Yamashita Y; Sagara K; Arakawa A; Takahashi M
    Acta Radiol; 1994 Nov; 35(6):576-80. PubMed ID: 7946681
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A phase II trial of transcatheter arterial infusion chemotherapy with an epirubicin-Lipiodol emulsion for advanced hepatocellular carcinoma refractory to transcatheter arterial embolization.
    Tanaka T; Ikeda M; Okusaka T; Ueno H; Morizane C; Ogura T; Hagihara A; Iwasa S
    Cancer Chemother Pharmacol; 2008 Apr; 61(4):683-8. PubMed ID: 17541589
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of segmental transcatheter arterial chemoembolization on branched chain amino acids and tyrosine ratio in patients with hepatocellular carcinoma.
    Inoue H; Ito T; Siraki K; Sugimoto K; Sakai T; Oomori S; Takase K; Nakano T
    Int J Oncol; 2000 Nov; 17(5):977-80. PubMed ID: 11029501
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [The results of the chemoembolization of advanced hepatocellular carcinomas. The effect on the survival times, morphological findings and tumor markers].
    Wickenhöfer R; Hasan I; Schüller H; Reiser M; Hartlapp JH
    Rofo; 1992 Apr; 156(4):328-32. PubMed ID: 1373966
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effectiveness of Lipiodol in transcatheter arterial embolization of hepatocellular carcinoma.
    Nakao N; Uchida H; Kamino K; Nishimura Y; Ohishi H; Takayasu Y; Nakamura H; Kuroda C; Fujita M; Yoshioka H
    Cancer Chemother Pharmacol; 1992; 31 Suppl():S72-6. PubMed ID: 1333913
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Hepatic arterial infusion chemotherapy for advanced hepatocellular carcinoma providing a good QOL].
    Yamashita S; Niinobu T; Nakagawa S; Amano M; Nishikawa Y; Hayashida H; Higaki N; Fujita M; Sakon M
    Gan To Kagaku Ryoho; 2006 Nov; 33(12):1928-30. PubMed ID: 17212149
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacy of transcatheter embolization/chemoembolization (TAE/TACE) for the treatment of single hepatocellular carcinoma.
    Miraglia R; Pietrosi G; Maruzzelli L; Petridis I; Caruso S; Marrone G; Mamone G; Vizzini G; Luca A; Gridelli B
    World J Gastroenterol; 2007 Jun; 13(21):2952-5. PubMed ID: 17589945
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Total necrosis of hepatocellular carcinoma with a combination therapy of arterial infusion of chemotherapeutic lipiodol and transcatheter arterial embolization: report of 14 cases.
    Kenji J; Hyodo I; Tanimizu M; Tanada M; Nishikawa Y; Hosokawa Y; Mandai K; Moriwaki S
    Semin Oncol; 1997 Apr; 24(2 Suppl 6):S6-71-S6-80. PubMed ID: 9151920
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of CT findings with resected specimens after chemoembolization with iodized oil for hepatocellular carcinoma.
    Takayasu K; Arii S; Matsuo N; Yoshikawa M; Ryu M; Takasaki K; Sato M; Yamanaka N; Shimamura Y; Ohto M
    AJR Am J Roentgenol; 2000 Sep; 175(3):699-704. PubMed ID: 10954453
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [SMANCS/TAE for hepatocellular carcinoma: comparison with SMANCS/TAI].
    Shimizu T; Endou H
    Gan To Kagaku Ryoho; 1998 Feb; 25 Suppl 1():80-3. PubMed ID: 9512693
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Transarterial chemoembolization with cisplatin as second-line treatment for hepatocellular carcinoma unresponsive to chemoembolization with epirubicin-Lipiodol emulsion.
    Maeda N; Osuga K; Higashihara H; Tomoda K; Mikami K; Nakazawa T; Nakamura H; Tomiyama N
    Cardiovasc Intervent Radiol; 2012 Feb; 35(1):82-9. PubMed ID: 21203761
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Hepatocellular carcinoma treated by intraarterial injection of adriamycin/mitomycin C oil suspension alone or combined with cis-diaminodichloroplatinum].
    Inoue H; Miyazono N; Hori A; Kanetsuki I; Tanaka D; Fukukura Y; Tsuchimochi S; Hokotate H; Ida K; Ikeda K
    Gan To Kagaku Ryoho; 1993 Jun; 20(8):1049-53. PubMed ID: 8390227
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Transcatheter arterial embolization with SMANCS and epiADM for hepatocellular carcinoma].
    Ihaya T; Ametani M; Matsusue E
    Gan To Kagaku Ryoho; 1998 Feb; 25 Suppl 1():109-15. PubMed ID: 9512698
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Factors associated with survival exceeding 5 years after transcatheter arterial embolization for hepatocellular carcinoma.
    Yoshioka H; Sato M; Sonomura T; Terada M; Kishi K; Yoshikawa A
    Semin Oncol; 1997 Apr; 24(2 Suppl 6):S6-29-S6-37. PubMed ID: 9151914
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.